SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,502,232 | +152.2% | 272,213 | +178.0% | 0.01% | +175.0% |
Q2 2023 | $12,887,442 | +76.2% | 97,914 | +76.9% | 0.00% | +33.3% |
Q4 2022 | $7,313,263 | +8.2% | 55,349 | -7.9% | 0.00% | 0.0% |
Q3 2022 | $6,759,000 | -17.1% | 60,104 | -44.1% | 0.00% | -25.0% |
Q2 2022 | $8,153,000 | -78.4% | 107,596 | -77.6% | 0.00% | -77.8% |
Q1 2022 | $37,832,000 | +1922.0% | 481,366 | +2237.0% | 0.02% | +1700.0% |
Q4 2021 | $1,871,000 | -92.7% | 20,598 | -92.7% | 0.00% | -91.7% |
Q3 2021 | $25,597,000 | +6380.3% | 282,309 | +5642.7% | 0.01% | – |
Q2 2021 | $395,000 | +42.1% | 4,916 | +26.9% | 0.00% | – |
Q1 2021 | $278,000 | -96.9% | 3,875 | -96.1% | 0.00% | -100.0% |
Q4 2020 | $8,841,000 | -44.6% | 98,485 | -13.9% | 0.01% | -53.8% |
Q3 2020 | $15,964,000 | +5.0% | 114,435 | +28.0% | 0.01% | -7.1% |
Q2 2020 | $15,199,000 | +3827.4% | 89,435 | +2119.2% | 0.01% | – |
Q1 2020 | $387,000 | -89.5% | 4,030 | -85.9% | 0.00% | -100.0% |
Q4 2019 | $3,678,000 | +70.8% | 28,499 | -0.3% | 0.00% | +50.0% |
Q3 2019 | $2,153,000 | -75.9% | 28,575 | -51.4% | 0.00% | -71.4% |
Q2 2019 | $8,937,000 | +9.3% | 58,814 | -14.2% | 0.01% | 0.0% |
Q1 2019 | $8,174,000 | -62.8% | 68,581 | -65.9% | 0.01% | -66.7% |
Q4 2018 | $21,950,000 | +36.9% | 201,135 | +102.6% | 0.02% | +61.5% |
Q3 2018 | $16,034,000 | +12.4% | 99,276 | -8.0% | 0.01% | +8.3% |
Q2 2018 | $14,267,000 | +196.5% | 107,933 | +66.2% | 0.01% | +200.0% |
Q1 2018 | $4,811,000 | +0.9% | 64,951 | -24.2% | 0.00% | 0.0% |
Q4 2017 | $4,770,000 | +24.3% | 85,707 | +1.3% | 0.00% | 0.0% |
Q3 2017 | $3,838,000 | +15.3% | 84,604 | -14.3% | 0.00% | +33.3% |
Q2 2017 | $3,329,000 | +13.9% | 98,775 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $2,924,000 | -12.7% | 98,775 | +1.0% | 0.00% | -25.0% |
Q4 2016 | $3,349,000 | -74.8% | 97,779 | -54.7% | 0.00% | -73.3% |
Q3 2016 | $13,269,000 | +76.8% | 216,060 | -45.1% | 0.02% | +66.7% |
Q2 2016 | $7,506,000 | +1637.5% | 393,601 | +1679.2% | 0.01% | – |
Q1 2016 | $432,000 | +1700.0% | 22,122 | +3272.3% | 0.00% | – |
Q4 2015 | $24,000 | +50.0% | 656 | +27.4% | 0.00% | – |
Q3 2015 | $16,000 | 0.0% | 515 | 0.0% | 0.00% | – |
Q2 2015 | $16,000 | +220.0% | 515 | +24.1% | 0.00% | – |
Q1 2015 | $5,000 | -16.7% | 415 | 0.0% | 0.00% | – |
Q4 2014 | $6,000 | +50.0% | 415 | +150.0% | 0.00% | – |
Q3 2014 | $4,000 | -87.9% | 166 | -85.0% | 0.00% | – |
Q2 2014 | $33,000 | +725.0% | 1,106 | +566.3% | 0.00% | – |
Q1 2014 | $4,000 | -20.0% | 166 | -37.6% | 0.00% | – |
Q4 2013 | $5,000 | -61.5% | 266 | 0.0% | 0.00% | – |
Q3 2013 | $13,000 | +116.7% | 266 | +60.2% | 0.00% | – |
Q2 2013 | $6,000 | – | 166 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |